Enjoy this free resource by Fight CRC! Thank you to our sponsor Merck Oncology for making this resource possible!
Immunotherapy, also called immunology or immuno-oncology, uses the body’s own immune system to fight off cancer and the spread of tumors. Immunotherapy is showing a lot of promise. Biomarker testing can tell you if current immunotherapies are an option for CRC patients. Watch as the following individuals explain biomarker testing, MSI status, CRC immunotherapies & the opportunities for more work to be done to impact a larger subset of patients.
The Video Features:
- Dr. Tom Marsilje, stage IV survivor & cancer drug discovery scientist
- Dr. Dung Le, colorectal cancer physician and researcher at John Hopkins Sidney Kimmel Cancer Center
- Suzanne Yavor & the Cole family, financial supporters of Fight CRC’s immunotherapy work